These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 29940750)
1. Alpha1,2-fucosyl transferase gene, the key enzyme of Lewis y synthesis, promotes Taxol resistance of ovarian carcinoma through apoptosis-related proteins. Li FF; Sha D; Qin XY; Li CZ; Lin B Neoplasma; 2018; 65(4):515-522. PubMed ID: 29940750 [TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer]. Tang X; Lu M; Li C; Deng S; Li M Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells. Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592 [TBL] [Abstract][Full Text] [Related]
4. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression. Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946 [TBL] [Abstract][Full Text] [Related]
5. [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer]. Tang XH; Lu MS; Deng S; Li M Zhonghua Fu Chan Ke Za Zhi; 2017 Feb; 52(2):110-115. PubMed ID: 28253574 [No Abstract] [Full Text] [Related]
6. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer. Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907 [TBL] [Abstract][Full Text] [Related]
7. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer]. Tang XH; Lu MS; Deng S; Li M Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):255-261. PubMed ID: 31006192 [No Abstract] [Full Text] [Related]
8. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1. Gan CZ; Li G; Luo QS; Li HM IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895 [TBL] [Abstract][Full Text] [Related]
9. c-Jun transcriptionally regulates alpha 1, 2-fucosyltransferase 1 (FUT1) in ovarian cancer. Gao N; Liu J; Liu D; Hao Y; Yan L; Ma Y; Zhuang H; Hu Z; Gao J; Yang Z; Shi H; Lin B Biochimie; 2014 Dec; 107 Pt B():286-92. PubMed ID: 25239830 [TBL] [Abstract][Full Text] [Related]
10. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer. Hao Y; Zhu L; Yan L; Liu J; Liu D; Gao N; Tan M; Gao S; Lin B Oncol Rep; 2017 Dec; 38(6):3355-3366. PubMed ID: 29130097 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763 [TBL] [Abstract][Full Text] [Related]
12. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells]. Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448 [TBL] [Abstract][Full Text] [Related]
13. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel]. Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496 [TBL] [Abstract][Full Text] [Related]
15. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol]. Shi XY; Cai XJ; Lei JX; Cao FJ; Pan DF; Chen P Ai Zheng; 2008 Apr; 27(4):343-7. PubMed ID: 18423117 [TBL] [Abstract][Full Text] [Related]
16. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637 [TBL] [Abstract][Full Text] [Related]
17. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer]. Tang J; Cao L; Yi H; Tang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375 [TBL] [Abstract][Full Text] [Related]
18. [Study on the Relationship Between Yue C; Li RH; Chen C; Liu H Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):337-341. PubMed ID: 30014630 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385 [TBL] [Abstract][Full Text] [Related]
20. [Effect of estrogen or progesterone combined with paclitaxel on human ovarian cancer cell growth and Drosha expression]. Yang Y; Han K; Xie Y Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):578-84. PubMed ID: 26714597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]